|
TOP1P2 expression based on
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.190000E-02 |
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.926000E-02 |
| Normal-vs-Stage2 |
5.301400E-01 |
| Normal-vs-Stage3 |
7.071800E-02 |
| Normal-vs-Stage4 |
4.337200E-01 |
| Stage1-vs-Stage2 |
3.151400E-01 |
| Stage1-vs-Stage3 |
9.793800E-01 |
| Stage1-vs-Stage4 |
4.133600E-01 |
| Stage2-vs-Stage3 |
3.966600E-01 |
| Stage2-vs-Stage4 |
8.850200E-01 |
| Stage3-vs-Stage4 |
4.973600E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.846000E-02 |
| Normal-vs-AfricanAmerican |
1.161420E-01 |
| Normal-vs-Asian |
2.648000E-01 |
| Caucasian-vs-AfricanAmerican |
3.356200E-01 |
| Caucasian-vs-Asian |
6.943200E-01 |
| AfricanAmerican-vs-Asian |
3.527600E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.165000E-03 |
| Normal-vs-Female |
1.258570E-01 |
| Male-vs-Female |
4.396000E-02 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.010050E-02 |
| Normal-vs-Age(41-60Yrs) |
1.270840E-01 |
| Normal-vs-Age(61-80Yrs) |
9.962200E-01 |
| Normal-vs-Age(81-100Yrs) |
4.318200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.317800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.543300E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.415200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.543600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.407000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.685700E-02 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.667400E-01 |
| Classical-VS-Follicular |
4.665200E-01 |
| Classical-VS-Other |
4.748800E-01 |
| Classical-VS-Normal |
2.565700E-02 |
| Tall-VS-Follicular |
8.086600E-01 |
| Tall-VS-Other |
2.666800E-01 |
| Tall-VS-Normal |
4.549000E-01 |
| Follicular-VS-Other |
3.407200E-01 |
| Follicular-VS-Normal |
2.141800E-01 |
| Other-VS-Normal |
7.831500E-02 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.565400E-01 |
| Normal-vs-N1 |
4.040200E-03 |
| N0-vs-N1 |
1.246490E-02 |
|
|
